Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FJSMJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,203
Award facts
- Contract value 100% obligated
- $17,203.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for Vraylar 3 mg capsules in a 30-count package. The contract ceiling value is $17,203.08 with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation and represents a small but specific pharmaceutical supply requirement within the DLA's broader procurement framework.
This award is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables the DLA to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a crucial supplier in the federal pharmaceutical supply chain through consistent contract performance and its comprehensive portfolio of branded and generic drugs, specialty medications, and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FJSMJ?
SPE2DB25FJSMJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJSMJ worth?
The government has obligated $17,203 on SPE2DB25FJSMJ.
Is contract SPE2DB25FJSMJ an order under another contract?
Yes. SPE2DB25FJSMJ is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB25FJSMJ competed?
The extent of competition for SPE2DB25FJSMJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award